scholarly journals Redo coronary bypass grafting for congenital left main coronary atresia: a case report

2017 ◽  
Vol 12 (1) ◽  
Author(s):  
Shin Yajima ◽  
Koichi Toda ◽  
Hiroyuki Nishi ◽  
Daisuke Yoshioka ◽  
Teruya Nakamura ◽  
...  
2010 ◽  
Vol 13 (3) ◽  
pp. E200-E201
Author(s):  
Amir K. Bigdeli ◽  
Eckehard Kilian ◽  
Andres Beiras-Fernandez ◽  
Ferdinand Vogt ◽  
Bruno Reichart ◽  
...  

Author(s):  
Christine Hughes ◽  
Bruno Farah ◽  
Jean Fajadet

Significant unprotected left main coronary artery (ULMCA) disease occurs in 5–7% of patients undergoing coronary angiography (and patients with ULMCA disease treated medically have a 3-year mortality rate of 50%. Several studies have shown a significant benefit following treatment of left main (LM) stenosis with coronary bypass grafting compared with medical treatment. Until recently coronary bypass grafting has been the gold standard therapy for LM disease. However, advances in percutaneous intervention techniques and stent technology have allowed re-evaluation of the role of percutaneous coronary intervention (PCI) for LM disease. Recent studies have focused on the safety and efficacy of stenting the left main coronary artery (LMCA) to determine if it does provide a true alternative to coronary artery bypass grafting (CABG). So should we stent the LM?


1998 ◽  
Vol 81 (3) ◽  
pp. 343-346 ◽  
Author(s):  
Albert Yuh-Jer Shen ◽  
Ravi Jandhyala ◽  
Christopher Ruel ◽  
Robert J Lundstrom ◽  
Michael B Jorgensen

1992 ◽  
Vol 21 (2) ◽  
pp. 212-215
Author(s):  
Tetsuo MIZUTANI ◽  
Katsumoto HATANAKA ◽  
Yoshihiko KATAYAMA ◽  
Takane HIRAIWA ◽  
Hiroshi YUASA ◽  
...  

2009 ◽  
Vol 36 (4) ◽  
pp. 616-620 ◽  
Author(s):  
George Naveen Thomas ◽  
Eliana Cecilia Martinez ◽  
Felix Woitek ◽  
Maximilian Y. Emmert ◽  
Hisashi Sakaguchi ◽  
...  

2010 ◽  
Vol 58 (S 01) ◽  
Author(s):  
J Schönebeck ◽  
B Reiter ◽  
O Haye ◽  
D Böhm ◽  
M Ismail ◽  
...  

2011 ◽  
Vol 14 (1) ◽  
pp. 12
Author(s):  
Onur Sokullu ◽  
Numan Ali Aydemir ◽  
Erol Kurc ◽  
Batuhan Ozay ◽  
Fuat Bilgen ◽  
...  

Background: Increased experience and improvements in technology seem to have encouraged the use of percutaneous interventions for left main coronary artery (LMCA) occlusions. There is no consensus, however, and the data are inadequate on whether surgery or percutaneous procedures should be the intervention of choice for critical occlusions.Methods: From January 2002 to December 2006, 108 patients with unprotected LMCA stenosis >80% were treated at our center. Eighty-three patients (77%) underwent bypass grafting and 20 (18%) underwent percutaneous intervention for the purpose of myocardial revascularization. We analyzed parameters demonstrated as risk factors for myocardial revascularization and their predicted effects on outcome.Results: Five patients (5%) died following emergency cardiopulmonary resuscitation before any intervention was performed. The early survival rate was 84.1% in the coronary bypass group and 63% in the percutaneous intervention group. The mean (SD) survival time was 55.7 2.6 months in the bypass group and 7.6 1.3 months in the percutaneous group. The late-survival rate was also significantly higher in the bypass group. The mean late-survival time was 44.5 3.6 months in the bypass group and 2.3 0.8 months in the percutaneous group.Conclusion: Although emergency percutaneous interventions are lifesaving in some cases, these results clearly demonstrate that coronary bypass grafting should be the intervention of choice for myocardial revascularization in patients with critical LMCA occlusion.


Sign in / Sign up

Export Citation Format

Share Document